Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w

Fully-endoscopic mitral valve surgery in obese patients
O. Bhadra1, J. Pausch1, P. Stolfa1, X. Hua1, D. Kalbacher2, N. Schofer2, S. Blankenberg2, A. Schäfer1, H. Reichenspurner1, L. Conradi1
1Klinik und Poliklinik für Herz- und Gefäßchirurgie, Universitäres Herz- und Gefäßzentrum Hamburg, Hamburg; 2Klinik für Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg, Hamburg;

Objectives

Obesity may challenge surgeons performing fully-endoscopic mitral valve surgery (EMS) and affect clinical outcomes. Therefore, the aim of this study is to evaluate the outcome of pre-obese and obese patients undergoing EMS at our center.

Methods                                                                                                                      

From 2015 –2021, 605 patients underwent EMS including cases with concomitant atrial ablation and/or left atrial appendage closure. Patients were stratified by normal-weight (group 1 = BMI 20-25; n=312); pre-obese (group 2 = BMI 25-30; n=226) and obese (group 3 = BMI >30; n=67). Baseline characteristics are presented in table 1. Group 1 was considered control group in a comparative analysis.

Results

Severe mitral regurgitation (MR) was the main indication in the overall cohort (97.8%). Mitral valve repair and replacement were performed in 92.7% and 7.3%, respectively. There were no differences in the rate of concomitant atrial ablation between groups (group 1 vs. 2: 18.9 vs. 20.6%, p=0.64; group 1 vs. 3: 18.9 vs 16%, p=0.36). Cardiopulmonary bypass time (CPBT) and cross clamp time (CCT) were significantly lower in group 1 compared to group 2 and 3 (CPBT: 162.8±45.1 vs. 183.2±60.9min, p=<0.001; 162.8±45.1 vs. 178.9±50.9, p=0.01) (CCT 97.6±34.6 vs. 109.1±39.2min, p<0.001; 97.6±34.6 vs. 107.4±36.8 min, p=0.04). ICU length of stay was also significantly longer in group 2 and 3 (2.1±1.7 vs. 2.8±4.0days, p=0.005; 2.1±1.7 vs. 3.2±4.9days, p=0.001. The overall rate of wound healing disorders was very low at 0.8% with no significant difference between groups. Stroke rate in the overall cohort was 0%. Rate of re-thoracotomy of group 1 showed no significant difference compared to group 2 and 3 (5.9 vs. 7.1%, p=0.68; 5.9 vs. 7.5%, p=0.58). Rates of mortality were low in all groups and showed no significant difference (0 vs. 0.9%, p=0.65; 0 vs. 1.5%, p=0.17).

Conclusion

EMS can be safely performed in pre-obese and obese patients with similarly favourable clinical and hemodynamic results despite prolonged cardiopulmonary bypass and aortic cross-clamp times and duration of ICU stay.

Table 1.)

Variable

Group 1

(n=312)

Group 2

(n=226)

Group3

(n=67)

Group 1 vs. 2

p-value

Group 1 vs. 3

p-value

Age (years)

59.6±12.4

60.5±11.1

59.5±10.8

0.34

1.0

Male (%)

60.0

76.8

74.4

<0.001

0.04

COPD (%)

2.5

3.5

6.0

0.29

0.22

Prior stroke (%)

3.1

6.2

3.0

0.48

1.0

Dialysis (%)

0.6

0.4

0

1.0

1.0

LVEF (%)

57.8±11.8

56.8±14.9

56.7±9.2

0.39

0.53

 


https://dgk.org/kongress_programme/jt2023/aP2093.html